Peripheral Blood Gene Expression Profile for Radiation Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for accurately screening large populations for ionizing radiation exposure are inadequate, particularly in distinguishing between irradiated and non-irradiated individuals, and there is a need to determine the specificity and durability of peripheral blood (PB) gene expression profiles in response to radiation exposure.
Innovation Solution
A method using a 25-gene metagene profile in PB cells to distinguish radiation status, which involves collecting PB, isolating mononuclear cells, extracting RNA, amplifying it, and using microarray techniques to determine gene expression levels, with kits including array probes and specific primers to amplify these genes, accounting for sex, genotype, and time variations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If gene expression profiling of peripheral blood cells is used to screen for radiation exposure, then the sensitivity and accuracy of detection is improved, but the complexity of the screening method and cost increase
Solution Approach 1:
The patent segments the gene expression profiling into a focused panel of specific genes (e.g., p53 pathway genes, DNA repair genes) rather than analyzing all genes. This segmentation maintains high detection accuracy for radiation exposure while reducing the complexity and cost compared to comprehensive gene expression analysis.
Solution Approach 2:
The patent applies partial action by selecting only the most radiation-responsive genes for profiling, rather than analyzing the entire transcriptome. This partial approach achieves sufficient detection accuracy for radiation exposure screening while significantly reducing methodological complexity and resource requirements.
2Reliability
If a comprehensive gene expression profile is analyzed to distinguish radiation exposure from other genotoxic stresses, then the specificity of detection is improved, but the time and computational resources required increase
Solution Approach 1:
The patent extracts and analyzes only the specific gene expression changes that are unique to radiation exposure, separating these from the broader spectrum of genotoxic stress responses. By focusing on radiation-specific molecular signatures rather than general DNA damage responses, the method achieves high specificity while reducing analysis time.
Solution Approach 2:
The patent applies local quality by identifying and measuring specific gene expression patterns that are characteristic of radiation exposure in particular cell types or time points. This localized approach to measuring specific molecular markers enables rapid and specific radiation detection without requiring comprehensive analysis of all possible stress responses.
3Ease of operation
If peripheral blood samples are collected and processed using standard protocols, then the ease of operation is improved, but the quantity of RNA obtained is insufficient for accurate gene expression analysis
Solution Approach 1:
The patent applies preliminary action by collecting and stabilizing RNA from peripheral blood mononuclear cells at the time of sample collection, before RNA degradation can occur. This preliminary stabilization ensures sufficient RNA quantity and quality for subsequent gene expression analysis while maintaining the simplicity of peripheral blood collection.
Solution Approach 2:
The patent uses copying by amplifying the RNA or cDNA from the limited peripheral blood sample to generate sufficient material for gene expression profiling. This amplification approach enables accurate measurement of gene expression from small RNA quantities while maintaining the ease of peripheral blood collection.
Data Source
AI summary
The present invention relates, in general, to gene expression profiles, and in particular, to a peripheral blood gene expression profile of an environmental exposure, ionizing radiation. The invention further relates to methods of screening patients for radiation exposure based on gene expression profiling and to kits suitable for use in such methods.